← Back
$CPRX All transactions

CATALYST PHARMACEUTICALS, INC.

M

$ Value

Shares

11,873

Price

Filed

Dec 10

Insider

Name

Miller Steve

Title

Chief Op. & Scientific Officer

CIK

0001402535

Roles

Officer

Transaction Details

Transaction Date

2025-12-08

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,079,803

Footnotes

Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting. | Derivative securities vested in equal tranches, 1/3rd on December 8, 2024, 1/3rd on December 8, 2025 and 1/3rd on December 8, 2026. | Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 8, 2025.

Filing Info

Accession No.

0001161697-25-000448

Form Type

4

Issuer CIK

0001369568

Miller Steve's History

Date Ticker Type Value
2025-12-29 CPRX M
2025-12-29 CPRX M $0
2025-12-08 CPRX M
2025-12-08 CPRX M $0
2025-11-21 CPRX M
2025-11-21 CPRX M $0
2025-11-20 CPRX A $0
2025-11-20 CPRX A $0
2025-08-27 CPRX M $246K
2025-08-27 CPRX M $0

Other Insiders at CPRX (90d)

Insider Bought Sold Last
Russo Gregg
Chief HR Officer
2026-02-17